A trial of intermittent rifampicin and ethambutol in retreatment regimens.
D000328:Adult; D002478:Cells, Cultured; D002543:Cerebral Hemorrhage / Q000139:chemically induced; D056486:Chemical and Drug Induced Liver Injury; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000008:administration & dosage* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D011696:Purpura, Thrombocytopenic / Q000139:chemically induced; D012293:Rifampin / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D013183:Sputum / Q000382:microbiology; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D004977:Ethambutol; D012293:Rifampin